These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 22058059)

  • 1. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.
    Wang J; Ding Q; Shi Y; Cao Q; Qin C; Zhu J; Chen J; Yin C
    Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CXCL12 G801A polymorphism and cancer risk: evidence from 17 case-control studies.
    Gong H; Tan M; Wang Y; Shen B; Liu Z; Zhang F; Liu Y; Qiu J; Bao E; Fan Y
    Gene; 2012 Nov; 509(2):228-31. PubMed ID: 22939870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the interleukin-10 gene polymorphism (-1082A/G) with systemic lupus erythematosus: a meta-analysis.
    Zhou M; Ding L; Peng H; Wang B; Huang F; Xu WD; Li JH; Ye XR; Pan HF; Ye DQ
    Lupus; 2013 Feb; 22(2):128-35. PubMed ID: 23192326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The -1082A/G polymorphism in the Interleukin-10 gene and the risk of rheumatoid arthritis: a meta-analysis.
    Zhang J; Zhang Y; Jin J; Li M; Xie K; Wen C; Cheng R; Chen C; Lu J
    Cytokine; 2011 Nov; 56(2):351-5. PubMed ID: 21764596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cox-2 -1195 G > A polymorphism and cancer risk: a meta-analysis of 25 case-control studies.
    Tang Z; Nie ZL; Pan Y; Zhang L; Gao L; Zhang Q; Qu L; He B; Song G; Zhang Y; Shukui Wang
    Mutagenesis; 2011 Nov; 26(6):729-34. PubMed ID: 21734230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in cancer: a meta-analysis.
    Jing JJ; Li M; Yuan Y
    Gene; 2012 May; 499(2):237-42. PubMed ID: 22441122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-10-1082A/G polymorphism and inflammatory bowel disease susceptibility: a meta-analysis based on 17,585 subjects.
    Zhu H; Lei X; Liu Q; Wang Y
    Cytokine; 2013 Jan; 61(1):146-53. PubMed ID: 23046617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour necrosis factor alpha -308G/A polymorphism and risk of the four most frequent cancers: a meta-analysis.
    Wang J; Cao C; Luo H; Xiong S; Xu Y; Xiong W
    Int J Immunogenet; 2011 Aug; 38(4):311-20. PubMed ID: 21624061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic association of interleukin-10 promoter polymorphisms and susceptibility to diffuse large B-cell lymphoma: a meta-analysis.
    Cao HY; Zou P; Zhou H
    Gene; 2013 May; 519(2):288-94. PubMed ID: 23485354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
    Ahirwar D; Mandhani A; Mittal RD
    Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The associations between two polymorphisms in the interleukin-10 gene promoter and breast cancer risk.
    Yu KD; Chen AX; Yang C; Fan L; Huang AJ; Shao ZM
    Breast Cancer Res Treat; 2012 Jan; 131(1):27-31. PubMed ID: 20737205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis.
    Yu KD; Chen AX; Shao ZM
    Breast Cancer Res Treat; 2010 Aug; 122(3):853-8. PubMed ID: 20076999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Interleukin-10 -1082A>G (rs1800896) Polymorphism with Predisposition to Breast Cancer: a Meta-Analysis based on 17 Case-Control Studies.
    Abedinzadeh M; Neamatzadeh H; Jafari M; Forat-Yazdi M; Nasiri R; Farahnak S; Foroughi E; Zare-Shehneh M
    Rev Assoc Med Bras (1992); 2018 Aug; 64(8):756-764. PubMed ID: 30673047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between CTLA-4 exon-1 +49A>G polymorphism and primary biliary cirrhosis risk: a meta-analysis.
    Huang Q; Shao F; Wang C; Qiu LJ; Hu YG; Yu JH
    Arch Med Res; 2011 Apr; 42(3):235-8. PubMed ID: 21722820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between IL-10 gene -1082A/G and -592C/A polymorphisms and the risk of hepatitis C infection: a meta-analysis.
    Sun XR; Wu J; Shi KQ; Tang KF
    J Viral Hepat; 2013 Sep; 20(9):602-11. PubMed ID: 23910644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between IL13 gene polymorphisms and susceptibility to cancer: a meta-analysis.
    Su T; Mi Y; Zhang L; Wang S; Lu H; Shi L; Sun H; Wu X; Zhang W; Zuo L; Zou J
    Gene; 2013 Feb; 515(1):56-61. PubMed ID: 23246181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interleukin-10-1082A>G polymorphism and lymphoma risk: a meta-analysis.
    Yu X; Chen B; Cheng J; Gao C; Zhang X; Bao W
    Cancer Biomark; 2014; 14(5):381-8. PubMed ID: 25171480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
    Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
    BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-10 polymorphisms and prostate cancer risk: a meta-analysis.
    Shao N; Xu B; Mi YY; Hua LX
    Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):129-35. PubMed ID: 21339768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 1 beta (IL1B) promoter polymorphism and cancer risk: evidence from 47 published studies.
    He B; Zhang Y; Pan Y; Xu Y; Gu L; Chen L; Wang S
    Mutagenesis; 2011 Sep; 26(5):637-42. PubMed ID: 21653279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.